Diabetes and Kidney Stones: Understanding the Connection
People with diabetes (especially type 2) have a 1.5–2× higher risk of kidney stones (nephrolithiasis) than the general population.
Mechanistic Links
| Factor | Effect in Diabetes | Stone Risk |
|---|
| Hypercalciuria | Insulin resistance → ↓ renal calcium reabsorption; acidic urine ↓ citrate | ↑ Calcium oxalate/phosphate stones |
| Hypocitraturia | Insulin normally ↑ citrate excretion; insulin resistance → ↓ citrate (inhibitor) | ↑ Calcium stones |
| Low urine pH | Impaired ammoniagenesis; ↑ net acid excretion | ↑ Uric acid stones (pH <5.5) |
| Dehydration | Hyperglycemia → osmotic diuresis; neurogenic bladder → incomplete emptying | ↑ Concentration of all stone formers |
| Obesity | Common in T2DM; ↑ uric acid, oxalate, calcium excretion; ↓ citrate | Independent risk factor |
| Metabolic syndrome | Dyslipidemia, hypertension correlate with stone formation | Synergistic |
Stone Types in Diabetes
- Calcium oxalate (most common overall).
- Uric acid (disproportionately higher in DM vs. non‑DM).
- Mixed calcium oxalate/phosphate.
Prevention Strategies for Diabetics
- Hydration: ≥2.5–3 L urine output/day (pale yellow urine).
- Glycemic control: HbA1c <7% reduces hypercalciuria, improves urine pH.
- Diet: DASH/Mediterranean – high fruits/veggies (citrate), moderate animal protein, low sodium (<2.3 g), normal calcium (1000–1200 mg).
- Weight management: 5–10% loss improves metabolic parameters.
- Medication review: SGLT2 inhibitors → ↑ UTI risk but neutral/beneficial for stones; topiramate/zonisamide → ↑ stone risk (carbonic anhydrase inhibition).
- 24‑hr urine metabolic panel if recurrent stones – guides targeted therapy (potassium citrate, thiazide, allopurinol).
Integrating stone prevention into diabetes care reduces morbidity from both conditions.
Kidney Disease - Related Articles
